Search

everythinglearnresearchcommunity

for

Search:↓

Rhodococcus equi causes severe pneumonia in young foals, and effective vaccines are needed due to foals' weak immune responses.

Flutamide rarely causes liver toxicity in prostate cancer patients.

Tiny particles from stem cells help activate hair growth cells and encourage hair growth in mice without being toxic.

Nanozymes show promise for effective and safe cancer treatment.

Blocking the Wnt pathway could lead to new treatments for cancer and tissue repair but requires careful development to avoid side effects.

Skin's Regulatory T cells are crucial for maintaining skin health and could be targeted to treat immune-related skin diseases and cancer.

UV radiation can help sterilize wounds and promote healing but requires careful use to avoid damaging cells.

A new genetic region, 17q21.31, is linked to higher ovarian cancer risk.

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

The Wnt/β-catenin pathway helps tissue regeneration but can also cause fibrosis, and drugs that inhibit this pathway may aid in healing skin and heart tissues.

Six new genetic regions linked to early hair loss also connect to Parkinson's disease and prostate cancer, possibly leading to new treatments.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

Stress hormone corticosterone blocks a growth factor to slow down hair stem cell activity and hair growth.

Some common medications can harm male fertility, but many effects can be reversed.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Four genetic risk spots found for hair loss, with WNT signaling involved and a link to curly hair.

Hormonal treatment in transgender women reduces semen quality, but stopping treatment may improve it.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Some breast cancer chemotherapy can cause permanent hair loss.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Docetaxel and paclitaxel for breast cancer can cause permanent, severe hair loss.

Using CRISPR for gene editing in the body is promising but needs better delivery methods to be more efficient and specific.

Applying a specific inhibitor lightens skin and hair color.

Hair can regrow after certain stem cells are lost because other stem cells can take over their role.

WNT10A helps esophageal cancer cells spread and keep renewing themselves.

Some medications can cause acne, and stopping these drugs is the main treatment.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

Finasteride might lower the risk of low-grade prostate cancer but not high-grade cancer, while alpha-blockers might reduce high-grade cancer risk.

Some people experienced hair loss after mesotherapy treatments for hair loss.